Senior insider sale
Chief Legal Officer at DEFINIUM THERAPEUTICS, INC. — senior position signals high conviction
$77.9K
11.10K shares
What this filing means
SULLIVAN MARK plans to sell 11.10K shares of DEFINIUM THERAPEUTICS, INC. valued at approximately $77.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/25/2025ACC: 0001950047-25-002186
Officer· Chief Legal Officer
Since Feb 2026
11.10K
Shares to sell
$77.9K
Approx. market value
6.58K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted stock vesting under a registered plan
Compensation
3/25/2025
6.58KTotal acquired6.58K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/25/2025 | Restricted stock vesting under a registered plan Compensation | 6.58K | — |
| Total | 6.58K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
4.52K
Market value
$33.6K
12/26/2024
Planned — Approximate Date
NASDAQPlanned
Units to sell
6.58K
Market value
$44.3K
3/25/2025
Total
Units
11.10K
Value
$77.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
12/26/2024 | 4.52K | $33.6K | — | Completed |
| Planned — Approximate Date | ||||
3/25/2025 | 6.58K | $44.3K | NASDAQ | Planned |
| Total | 11.10K | $77.9K | ||